RNS Number:8992F
Celsis International PLC
01 December 2004


                             CAPITAL REORGANISATION

                            Celsis International plc

                       Reduction of Share Premium Account


1 December 2004: Celsis International plc (the "Company") announces that it has
received the requisite approvals to effect a capital reduction by way of
reduction of share premium account.


Enquiries:

  Celsis International plc                                  Tel: 01638 600 151
  Jay LeCoque, Chief Executive Officer
  Jenny Parsons, Corporate Communications

  Financial Dynamics                                        Tel: 020 7831 3113
  David Yates
  Lucy Briggs


Notes to editors

Celsis International plc

Celsis International Plc is a microbial detection and analytical services
company operating through two divisions, the Product Group and the Laboratory
Group.

Using its proprietary enzyme technology, the Product Group is the world leader
in the provision of diagnostic systems for the rapid detection of microbial
contamination.  It works in close collaboration with many of the world's leading
pharmaceutical, personal care and beverage companies, ensuring the safety and
quality of products bound for consumers.  The Laboratory Group provides
outsourced analytical testing services to pharmaceutical companies to ensure the
stability and chemical composition of their products.

In addition to ensuring product quality and safety for consumers, both divisions
have the capacity to deliver substantial cost savings to Celsis' customers.  By
reducing the time it takes to test and release raw materials and finished goods
to the market place, Celsis' products facilitate increased manufacturing
productivity and improved supply chain management.

Celsis International plc is listed on the London Stock Exchange (CEL.L).
Further information can be found on the Company's website at www.celsis.com.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
MSCEAKAFELNLFFE
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.